Related references
Note: Only part of the references are listed.Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis
Shunya Mashiko et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Interleukin-10-producing CD5(+) B cells inhibit mast cells during immunoglobulin E-mediated allergic responses
Hyuk Soon Kim et al.
SCIENCE SIGNALING (2015)
Interleukin-10-producing CD5(+) B cells inhibit mast cells during immunoglobulin E-mediated allergic responses
Hyuk Soon Kim et al.
SCIENCE SIGNALING (2015)
miRNA-155 controls mast cell activation by regulating the PI3Kγ pathway and anaphylaxis in a mouse model
K. Biethahn et al.
ALLERGY (2014)
Staphylococcal Enterotoxin B-Induced MicroRNA-155 Targets SOCS1 To Promote Acute Inflammatory Lung Injury
Roshni Rao et al.
INFECTION AND IMMUNITY (2014)
Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
Hui Peng et al.
CLINICAL RHEUMATOLOGY (2013)
miR-155: an ancient regulator of the immune system
Elena Vigorito et al.
IMMUNOLOGICAL REVIEWS (2013)
IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis
Christopher J. Moran et al.
INFLAMMATORY BOWEL DISEASES (2013)
Rheumatoid Arthritis-Associated MicroRNA-155 Targets SOCS1 and Upregulates TNF-α and IL-1β in PBMCs
Xiaochuan Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation
David A. Braun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Genotype-Dependent Effects of TGF-β1 on Mast Cell Function: Targeting the Stat5 Pathway
Josephine Fernando et al.
JOURNAL OF IMMUNOLOGY (2013)
Cytokine patterns in patients with cancer: a systematic review
Bodo E. Lippitz
LANCET ONCOLOGY (2013)
STAT3 Activates miR-155 in Th17 Cells and Acts in Concert to Promote Experimental Autoimmune Uveitis
Thelma Escobar et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response
Yixi Sun et al.
IMMUNOLOGY LETTERS (2012)
Interleukin-10 Inhibits Lipopolysaccharide-induced Tumor Necrosis Factor-α Translation through a SHIP1-dependent Pathway
Catherine S. Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Stem Cell Factor Programs the Mast Cell Activation Phenotype
Tomonobu Ito et al.
JOURNAL OF IMMUNOLOGY (2012)
MicroRNAs and STAT interplay
Gary Kohanbash et al.
SEMINARS IN CANCER BIOLOGY (2012)
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
Ulrik Ralfkiaer et al.
BLOOD (2011)
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis
Mariola Kurowska-Stolarska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IL-10 Inhibits miR-155 Induction by Toll-like Receptors
Claire E. McCoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 Protein
Li-Fan Lu et al.
IMMUNITY (2009)
Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis
Wolf-Dietrich Doecke et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Inositol phosphatase SHIP1 is a primary target of miR-155
Ryan M. O'Connell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo
Sarah Kennedy Norton et al.
JOURNAL OF IMMUNOLOGY (2008)
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock
Esmerina Tili et al.
JOURNAL OF IMMUNOLOGY (2007)
Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock
Y. Heper et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
The primary mechanism of the IL-10-regulated anti inflammatory response is to selectively inhibit transcription
PJ Murray
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Different roles of interleukin-10 in onset and resolution of asthmatic responses in allergen-challenged mice
K Matsumoto et al.
RESPIROLOGY (2005)
IL-10 inhibits FcεRI expression in mouse mast cells
SR Gillespie et al.
JOURNAL OF IMMUNOLOGY (2004)
Kit and FCεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells
TR Hundley et al.
BLOOD (2004)
Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially cytokine signaling 3
C Niemand et al.
JOURNAL OF IMMUNOLOGY (2003)
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ
H Tilg et al.
GUT (2002)
Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes
N Kambe et al.
BLOOD (2001)
An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model
T Kobayashi et al.
JOURNAL OF IMMUNOLOGY (2000)
Proinflammatory effects of IL-10 during human endotoxemia
FN Lauw et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
